<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Quantitative Health Sciences Publications and Presentations</title>
<copyright>Copyright (c) 2013 University of Massachusetts Medical School All rights reserved.</copyright>
<link>http://escholarship.umassmed.edu/qhs_pp</link>
<description>Recent documents in Quantitative Health Sciences Publications and Presentations</description>
<language>en-us</language>
<lastBuildDate>Thu, 16 May 2013 14:02:23 PDT</lastBuildDate>
<ttl>3600</ttl>








<item>
<title>The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1107</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1107</guid>
<pubDate>Mon, 29 Apr 2013 06:02:16 PDT</pubDate>
<description>
	<![CDATA[
	<p>Summary points:  <ul> <li>In cluster randomized trials (CRTs), the units of allocation, intervention, and outcome measurement may differ within a single trial. As a result of the unique design of CRTs, the interpretation of existing research ethics guidelines is complicated.</li> <li>The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials aims to provide researchers and research ethics committees (RECs) with detailed guidance on the ethical design, conduct, and review of CRTs.</li> <li>A five-year mixed methods research project explored the ethical challenges of CRTs. Empirical studies documented the reporting of ethical issues in published CRTs, interviewed experienced trialists, and surveyed trialists and REC chairs. The ethical issues identified were explored in a series of background papers that provided detailed ethical analyses and policy options, and a panel of experts using a systematic process developed a consensus statement.</li> <li>The Ottawa Statement sets out 15 recommendations for the ethical design and conduct of CRTs. The recommendations provide guidance on the justification of a cluster randomized design, the need for REC review, the identification of research participants, obtaining informed consent, the role of gatekeepers in protecting group interests, the assessment of benefits and harms, and the protection of vulnerable participants.</li> </ul></p>

	]]>
</description>

<author>Charles Weijer et al.</author>


<category>Cluster Analysis</category>

<category>Epidemiologic Research Design</category>

<category>Humans</category>

<category>Randomized Controlled Trials as Topic</category>

</item>






<item>
<title>Safety climate and medical errors in 62 US emergency departments</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1106</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1106</guid>
<pubDate>Mon, 22 Apr 2013 08:16:50 PDT</pubDate>
<description>
	<![CDATA[
	<p>STUDY OBJECTIVE: We describe the incidence and types of medical errors in emergency departments (EDs) and assess the validity of a survey instrument that identifies systems factors contributing to errors in EDs.</p>
<p>METHODS: We conducted the National Emergency Department Safety Study in 62 urban EDs across 20 US states. We reviewed 9,821 medical records of ED patients with one of 3 conditions (myocardial infarction, asthma exacerbation, and joint dislocation) to evaluate medical errors. We also obtained surveys from 3,562 staff randomly selected from each ED; survey data were used to calculate average safety climate scores for each ED.</p>
<p>RESULTS: We identified 402 adverse events (incidence rate 4.1 per 100 patient visits; 95% confidence interval [CI] 3.7 to 4.5) and 532 near misses (incidence rate 5.4 per 100 patient visits; 95% CI 5.0 to 5.9). We judged 37% of the adverse events, and all of the near misses, to be preventable (errors); 33% of the near misses were intercepted. In multivariable models, better ED safety climate was not associated with fewer preventable adverse events (incidence rate ratio per 0.2-point increase in ED safety score 0.82; 95% CI 0.57 to 1.16) but was associated with more intercepted near misses (incidence rate ratio 1.79; 95% CI 1.06 to 3.03). We found no association between safety climate and violations of national treatment guidelines.</p>
<p>CONCLUSION: Among the 3 ED conditions studied, medical errors are relatively common, and one third of adverse events are preventable. Improved ED safety climate may increase the likelihood that near misses are intercepted. Inc. All rights reserved.</p>

	]]>
</description>

<author>Carlos A. Camargo Jr. et al.</author>


<category>Emergency Service, Hospital</category>

<category>Female</category>

<category>Health Care Surveys</category>

<category>Humans</category>

<category>Incidence</category>

<category>Male</category>

<category>Medical Errors</category>

<category>Middle Aged</category>

<category>Organizational Culture</category>

<category>*Patient Safety</category>

<category>United States</category>

</item>






<item>
<title>Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: a pilot study</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1105</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1105</guid>
<pubDate>Mon, 22 Apr 2013 08:16:48 PDT</pubDate>
<description>
	<![CDATA[
	<p>We hypothesized that atomoxetine (ATMX) would produce similar brain effects in attention-deficit/hyperactivity disorder (ADHD) as those of methylphenidate (MPH). Eleven ADHD adults performed the Multi-Source Interference Task (MSIT) during functional magnetic resonance imaging (fMRI) at baseline and after 6 weeks of ATMX treatment. ATMX was associated with increased fMRI activation of dorsolateral prefrontal cortex, parietal cortex and cerebellum but not dorsal anterior midcingulate cortex (daMCC). These results suggest that ATMX and MPH have similar but not identical brain effects.</p>

	]]>
</description>

<author>George Bush et al.</author>


</item>






<item>
<title>Internet health information seeking is a team sport: analysis of the Pew Internet Survey</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1104</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1104</guid>
<pubDate>Mon, 22 Apr 2013 08:16:47 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Previous studies examining characteristics of Internet health information seekers do not distinguish between those who only seek for themselves, and surrogate seekers who look for health information for family or friends. Identifying the unique characteristics of surrogate seekers would help in developing Internet interventions that better support these information seekers.</p>
<p>OBJECTIVE: To assess differences between self seekers versus those that act also as surrogate seekers.</p>
<p>METHODS: We analyzed data from the cross-sectional Pew Internet and American Life Project November/December 2008 health survey. Our dependent variable was self-report of type of health information seeking (surrogate versus self seeking). Independent variables included demographics, health status, and caregiving. After bivariate comparisons, we then developed multivariable models using logistic regression to assess characteristics associated with surrogate seeking.</p>
<p>RESULTS: Out of 1250 respondents who reported seeking health information online, 56% (N=705) reported being surrogate seekers. In multivariable models, compared with those who sought information for themselves only, surrogate seekers were more likely both married and a parent (OR=1.57, CI=1.08, 2.28), having good (OR=2.05, CI=1.34, 3.12) or excellent (OR=2.72, CI=1.70, 4.33) health status, being caregiver of an adult relative (OR=1.76, CI=1.34, 2.30), having someone close with a serious medical condition (OR=1.62, CI=1.21, 2.17) and having someone close to them facing a chronic illness (OR=1.55, CI=1.17, 2.04).</p>
<p>CONCLUSIONS: Our findings provide evidence that information needs of surrogate seekers are not being met, specifically of caregivers. Additional research is needed to develop new functions that support surrogate seekers.</p>

	]]>
</description>

<author>Rajani S. Sadasivam et al.</author>


</item>






<item>
<title>Pre-travel health care of immigrants returning home to visit friends and relatives</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1103</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1103</guid>
<pubDate>Mon, 22 Apr 2013 08:16:46 PDT</pubDate>
<description>
	<![CDATA[
	<p>Immigrants returning home to visit friends and relatives (VFR travelers) are at higher risk of travel-associated illness than other international travelers. We evaluated 3,707 VFR and 17,507 non-VFR travelers seen for pre-travel consultation in Global TravEpiNet during 2009-2011; all were traveling to resource-poor destinations. VFR travelers more commonly visited urban destinations than non-VFR travelers (42% versus 30%, P < 0.0001); 54% of VFR travelers were female, and 18% of VFR travelers were under 6 years old. VFR travelers sought health advice closer to their departure than non-VFR travelers (median days before departure was 17 versus 26, P < 0.0001). In multivariable analysis, being a VFR traveler was an independent predictor of declining a recommended vaccine. Missed opportunities for vaccination could be addressed by improving the timing of pre-travel health care and increasing the acceptance of vaccines. Making pre-travel health care available in primary care settings may be one step to this goal.</p>

	]]>
</description>

<author>Regina C. LaRocque et al.</author>


<category>Adolescent</category>

<category>Adult</category>

<category>Aged</category>

<category>Child</category>

<category>Child, Preschool</category>

<category>Cohort Studies</category>

<category>Communicable Disease Control</category>

<category>*Delivery of Health Care</category>

<category>Emigrants and Immigrants</category>

<category>Female</category>

<category>Health Knowledge, Attitudes, Practice</category>

<category>*Health Planning Guidelines</category>

<category>Humans</category>

<category>Logistic Models</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Multivariate Analysis</category>

<category>*Public Health</category>

<category>Travel</category>

<category>Vaccination</category>

<category>Young Adult</category>

</item>






<item>
<title>Correlation of trabeculae and papillary muscles with clinical and cardiac characteristics and impact on cmr measures of LV anatomy and function</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1102</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1102</guid>
<pubDate>Mon, 22 Apr 2013 08:16:45 PDT</pubDate>
<description>
	<![CDATA[
	<p>OBJECTIVES: The goal of this study was to assess the relationship of left ventricular (LV) trabeculae and papillary muscles (TPM) with clinical characteristics in a community-based, free-living adult cohort and to determine the effect of TPM on quantitative measures of LV volume, mass, and ejection fraction (EF).</p>
<p>BACKGROUND: Hypertrabeculation has been associated with adverse cardiovascular events, but the distribution and clinical correlates of the volume and mass of the TPM in a normal left ventricle have not been well characterized.</p>
<p>METHODS: Short-axis cine cardiac magnetic resonance images, obtained using a steady-state free precession sequence from 1,494 members of the Framingham Heart Study Offspring cohort, were analyzed with software that automatically segments TPM. Absolute TPM volume, TPM as a fraction of end-diastolic volume (EDV) (TPM/EDV), and TPM mass as a fraction of LV mass were determined in all offspring and in a referent group of offspring free of clinical cardiovascular disease and hypertension.</p>
<p>RESULTS: In the referent group (mean age 61 +/- 9 years; 262 men and 423 women), mean TPM was 23 +/- 3% of LV EDV in both sexes (p = 0.9). TPM/EDV decreased with age (p < 0.02) but was not associated with body mass index. TPM mass as a fraction of LV mass was inversely correlated with age (p < 0.0001), body mass index (p < 0.018), and systolic blood pressure (p < 0.0001). Among all 1,494 participants (699 men), LV volumes decreased 23%, LV mass increased 28%, and EF increased by 7.5 EF units (p < 0.0001) when TPM were considered myocardial mass rather than part of the LV blood pool.</p>
<p>CONCLUSIONS: Global cardiac magnetic resonance LV parameters were significantly affected by whether TPM was considered as part of the LV blood pool or as part of LV mass. Our cross-sectional data from a healthy referent group of adults free of clinical cardiovascular disease demonstrated that TPM/EDV decreases with increasing age in both sexes but is not related to hypertension or obesity. Elsevier Inc. All rights reserved.</p>

	]]>
</description>

<author>Michael L. Chuang et al.</author>


</item>






<item>
<title>Identifying major hemorrhage with automated data: results of the veterans affairs study to improve anticoagulation (VARIA)</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1101</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1101</guid>
<pubDate>Mon, 22 Apr 2013 08:16:44 PDT</pubDate>
<description>
	<![CDATA[
	<p>INTRODUCTION: Identifying major bleeding is fundamental to assessing the outcomes of anticoagulation therapy. This drives the need for a credible implementation in automated data for the International Society of Thrombosis and Haemostasis (ISTH) definition of major bleeding.</p>
<p>MATERIALS AND METHODS: We studied 102,395 patients who received 158,511 person-years of warfarin treatment from the Veterans Health Administration (VA) between 10/1/06-9/30/08. We constructed a list of ICD-9-CM codes of "candidate" bleeding events. Each candidate event was identified as a major hemorrhage if it fulfilled one of four criteria: 1) associated with death within 30days; 2) bleeding in a critical anatomic site; 3) associated with a transfusion; or 4) was coded as the event that precipitated or was responsible for the majority of an inpatient hospitalization.</p>
<p>RESULTS: This definition classified 11,240 (15.8%) of 71, 338 candidate events as major hemorrhage. Typically, events more likely to be severe were retained at higher rates than those less likely to be severe. For example, Diverticula of Colon with Hemorrhage (562.12) and Hematuria (599.7) were retained 46% and 4% of the time, respectively. Major, intracranial, and fatal hemorrhage were identified at rates comparable to those found in randomized clinical trials however, higher than those reported in observational studies: 4.73, 1.29, and 0.41 per 100 patient years, respectively.</p>
<p>CONCLUSIONS: We describe here a workable definition for identifying major hemorrhagic events from large automated datasets. This method of identifying major bleeding may have applications for quality measurement, quality improvement, and comparative effectiveness research.</p>

	]]>
</description>

<author>Guneet K. Jasuja et al.</author>


</item>






<item>
<title>Holoendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1100</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1100</guid>
<pubDate>Mon, 22 Apr 2013 08:16:42 PDT</pubDate>
<description>
	<![CDATA[
	<p>Coinfection with Plasmodium falciparum malaria and Epstein-Barr virus (EBV) is a major risk factor for endemic Burkitt lymphoma (eBL), still one of the most prevalent pediatric cancers in equatorial Africa. Although malaria infection has been associated with immunosuppression, the precise mechanisms that contribute to EBV-associated lymphomagenesis remain unclear. In this study, we used polychromatic flow cytometry to characterize CD8(+) T-cell subsets specific for EBV-derived lytic (BMFL1 and BRLF1) and latent (LMP1, LMP2, and EBNA3C) antigens in individuals with divergent malaria exposure. No malaria-associated differences in EBV-specific CD8(+) T-cell frequencies were observed. However, based on a multidimensional analysis of CD45RO, CD27, CCR7, CD127, CD57, and PD-1 expression, we found that individuals living in regions with intense and perennial (holoendemic) malaria transmission harbored more differentiated EBV-specific CD8(+) T-cell populations that contained fewer central memory cells than individuals living in regions with little or no (hypoendemic) malaria. This profile shift was most marked for EBV-specific CD8(+) T-cell populations that targeted latent antigens. Importantly, malaria exposure did not skew the phenotypic properties of either cytomegalovirus (CMV)-specific CD8(+) T cells or the global CD8(+) memory T-cell pool. These observations define a malaria-associated aberration localized to the EBV-specific CD8(+) T-cell compartment that illuminates the etiology of eBL.</p>

	]]>
</description>

<author>Pratip K. Chattopadhyay et al.</author>


<category>Africa</category>

<category>CD8-Positive T-Lymphocytes</category>

<category>Child</category>

<category>Child, Preschool</category>

<category>Coinfection</category>

<category>Epstein-Barr Virus Infections</category>

<category>Flow Cytometry</category>

<category>Herpesvirus 4, Human</category>

<category>Humans</category>

<category>Infant</category>

<category>Malaria, Falciparum</category>

<category>Plasmodium falciparum</category>

<category>T-Lymphocyte Subsets</category>

</item>






<item>
<title>Gaps in monitoring during oral anticoagulation: insights into care transitions, monitoring barriers, and medication nonadherence</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1099</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1099</guid>
<pubDate>Mon, 22 Apr 2013 08:16:41 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Among patients receiving oral anticoagulation, a gap of andgt; 56 days between international normalized ratio tests suggests loss to follow-up that could lead to poor anticoagulation control and serious adverse events.</p>
<p>METHODS: We studied long-term oral anticoagulation care for 56,490 patients aged 65 years and older at 100 sites of care in the Veterans Health Administration. We used the rate of gaps in monitoring per patient-year to predict percentage time in therapeutic range (TTR) at the 100 sites.</p>
<p>RESULTS: Many patients (45%) had at least one gap in monitoring during an average of 1.6 years of observation; 5% had two or more gaps per year. The median gap duration was 74 days (interquartile range, 62-107). The average TTR for patients with two or more gaps per year was 10 percentage points lower than for patients without gaps (P andlt; .001). Patient-level predictors of gaps included nonwhite race, area poverty, greater distance from care, dementia, and major depression. Site-level gaps per patient-year varied from 0.19 to 1.78; each one-unit increase was associated with a 9.2 percentage point decrease in site-level TTR (P andlt; .001).</p>
<p>CONCLUSIONS: Site-level gap rates varied widely within an integrated care system. Sites with more gaps per patient-year had worse anticoagulation control. Strategies to address and reduce gaps in monitoring may improve anticoagulation control.</p>

	]]>
</description>

<author>Adam J. Rose et al.</author>


</item>






<item>
<title>Universal health outcome measures for older persons with multiple chronic conditions</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1098</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1098</guid>
<pubDate>Mon, 22 Apr 2013 08:16:40 PDT</pubDate>
<description>
	<![CDATA[
	<p>Older adults with multiple chronic conditions (MCCs) require considerable health services and complex care. Because the persistence and progression of diseases and courses of treatments affect health status in multiple dimensions, well-validated universal outcome measures across diseases are needed for research, clinical care, and administrative purposes. An expert panel meeting held by the National Institute on Aging in September 2011 recommends that older persons with MCCs complete a brief initial composite measure that includes general health; pain; fatigue; and physical health, mental health, and social role function, along with gait speed measurement. Suitable composite measures include the Medical Outcomes Study 8 (SF-8) and 36 (SF-36) -item Short-Form Survey and the Patient Reported Outcomes Measurement Information System 29-item Health Profile. Based on responses to items in the initial measure, short follow-on measures should be selectively targeted to symptom burden, depression, anxiety, and daily activities. Persons unable to walk a short distance to assess gait speed should be assessed using a physical function scale. Remaining gaps to be considered for measure development include disease burden, cognitive function, and caregiver burden. Routine outcome assessment of individuals with MCCs could facilitate system-based care improvement and clinical effectiveness research. Geriatrics Society. Conditions</p>

	]]>
</description>

<author>Karen Adams et al.</author>


<category>Activities of Daily Living</category>

<category>Aged</category>

<category>Chronic Disease</category>

<category>Cognition</category>

<category>*Comorbidity</category>

<category>Gait</category>

<category>*Health Status Indicators</category>

<category>Humans</category>

<category>Interpersonal Relations</category>

<category>Mental Health</category>

<category>*Outcome Assessment (Health Care)</category>

<category>Quality Assurance, Health Care</category>

<category>Social Support</category>

<category>Walking</category>

</item>






<item>
<title>Predicting hospital readmission: different approaches raise new questions about old issues</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1097</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1097</guid>
<pubDate>Mon, 22 Apr 2013 08:16:39 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Catarina I. Kiefe et al.</author>


<category>Forecasting</category>

<category>Hospital Administration</category>

<category>Hospital Charges</category>

<category>Humans</category>

<category>Medicare</category>

<category>Patient Readmission</category>

<category>Risk Adjustment</category>

<category>United States</category>

</item>






<item>
<title>Sampling considerations for health care improvement</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1096</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1096</guid>
<pubDate>Mon, 22 Apr 2013 08:16:38 PDT</pubDate>
<description>
	<![CDATA[
	<p>Sampling in improvement work can pose challenges. How is it different from the sampling strategies many use with research, clinical trials, or regulatory programs? What should improvement teams consider when determining a useful approach to sampling and a useful sample size? The aim of this article is to introduce some of the concepts related to sampling for improvement. We give specific guidance related to determining a useful sample size to a wider health care audience so that it can be applied to improvement projects in hospitals and health systems.</p>

	]]>
</description>

<author>Rocco J. Perla et al.</author>


</item>






<item>
<title>MedTxting: learning based and knowledge rich SMS-style medical text contraction</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1095</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1095</guid>
<pubDate>Mon, 22 Apr 2013 08:16:36 PDT</pubDate>
<description>
	<![CDATA[
	<p>In mobile health (M-health), Short Message Service (SMS) has shown to improve disease related self-management and health service outcomes, leading to enhanced patient care. However, the hard limit on character size for each message limits the full value of exploring SMS communication in health care practices. To overcome this problem and improve the efficiency of clinical workflow, we developed an innovative system, MedTxting (available at http://medtxting.askhermes.org), which is a learning-based but knowledge-rich system that compresses medical texts in a SMS style. Evaluations on clinical questions and discharge summary narratives show that MedTxting can effectively compress medical texts with reasonable readability and noticeable size reduction. Findings in this work reveal potentials of MedTxting to the clinical settings, allowing for real-time and cost-effective communication, such as patient condition reporting, medication consulting, physicians connecting to share expertise to improve point of care.</p>

	]]>
</description>

<author>Feifan LIu et al.</author>


</item>






<item>
<title>Using a resource effect study pre-pilot to inform a large randomized trial: the Decide2Quit.Org Web-assisted tobacco intervention</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1094</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1094</guid>
<pubDate>Mon, 22 Apr 2013 08:16:35 PDT</pubDate>
<description>
	<![CDATA[
	<p>Resource effect studies can be useful in highlighting areas of improvement in informatics tools. Before a large randomized trial, we tested the functions of the Decide2Quit.org Web-assisted tobacco intervention using smokers (N=204) recruited via Google advertisements. These smokers were given access to Decide2Quit.org for six months and we tracked their usage and assessed their six months cessation using a rigorous follow-up. Multiple, interesting findings were identified: we found the use of tailored emails to dramatically increase participation for a short period. We also found varied effects of the different functions. Functions supporting "seeking social support" (Your Online Community and Family Tools), Healthcare Provider Tools, and the Library had positive effects on quit outcomes. One surprising finding, which needs further investigation, was that writing to our Tobacco Treatment Specialists was negatively associated with quit outcomes.</p>

	]]>
</description>

<author>Rajani S. Sadasivam et al.</author>


</item>






<item>
<title>Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1093</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1093</guid>
<pubDate>Mon, 22 Apr 2013 08:16:34 PDT</pubDate>
<description>
	<![CDATA[
	<p>OBJECTIVES: To examine whether the total burden of comorbidity and pattern of co-occurring conditions varies in individuals with heart failure (HF) with preserved left ventricular ejection fraction (LVEF) (HF-P) or HF with reduced LVEF (HF-R). DESIGN: Cross-sectional cohort study.</p>
<p>SETTING: Four participating health plans within the National Heart, Lung, and Blood Institute-sponsored Cardiovascular Research Network.</p>
<p>PARTICIPANTS: All members aged 65 and older with HF based on hospital discharge and ambulatory visit diagnoses.</p>
<p>MEASUREMENTS: Participants with a LVEF of 50% or greater were classified as having HF-P. Presence of cardiac and noncardiac comorbidities was obtained from health plan administrative databases.</p>
<p>RESULTS: Of 23,435 individuals identified with HF and LVEF information, 53% (12,407) had confirmed HF-P (mean age 79.6; 60% female). More than three-quarters of the sample had three or more co-occurring conditions in addition to HF, and half had five or more cooccurring conditions. Participants with HF-P had a slightly higher burden of comorbidity than those with HF-R (mean 4.5 vs 4.4, P = .002). Patterns of how specific conditions co-occurred did not vary in participants with preserved or reduced systolic function.</p>
<p>CONCLUSION: There is a high degree of comorbidity and multiple morbidity in individuals with HF. The burden and pattern of comorbidity varies only slightly in individuals with preserved or reduced LVEF. Geriatrics Society.</p>

	]]>
</description>

<author>Jane S. Saczynski et al.</author>


<category>Adult</category>

<category>Aged</category>

<category>Aged, 80 and over</category>

<category>Comorbidity</category>

<category>Cross-Sectional Studies</category>

<category>Digestive System Diseases</category>

<category>Female</category>

<category>Follow-Up Studies</category>

<category>Heart Failure</category>

<category>History, Ancient</category>

<category>Humans</category>

<category>Male</category>

<category>Mental Disorders</category>

<category>Middle Aged</category>

<category>Neoplasms</category>

<category>Retrospective Studies</category>

<category>Stroke Volume</category>

<category>United States</category>

<category>Young Adult</category>

</item>






<item>
<title>Personal Health Record Use and Its Association with Antiretroviral Adherence: Survey and Medical Record Data from 1871 US Veterans Infected with HIV</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1092</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1092</guid>
<pubDate>Mon, 22 Apr 2013 08:16:33 PDT</pubDate>
<description>
	<![CDATA[
	<p>Patient electronic personal health record (PHR) use has been associated with improved patient outcomes in diabetes and depression care. Little is known about the effect of PHR use on HIV care processes and outcomes. We evaluated whether there was an association between patient PHR use and antiretroviral adherence. Data came from the Veterans Aging Cohort Study and included cross-sectional survey and medical record data from 1871 HIV+ veterans. Our adherence measure was an antiretroviral medication possession ratio, dichotomized at 0.90, and based on pharmacy refill data. In our sample 44 % did not use the internet, 14 % used internet but not for health, 27 % used internet for health but not the PHR, and 14 % used the PHR. In multivariable analysis PHR use was associated with >/=90 % adherence after controlling for socio-demographic variables. Findings provide support for longitudinal studies and studies that identify which PHR functions (e.g. online medication refills, viewing lab results, secure messaging with providers) are most closely associated with medication adherence.</p>

	]]>
</description>

<author>D. Keith McInnes et al.</author>


</item>






<item>
<title>Timing of video capsule endoscopy relative to overt obscure GI bleeding: implications from a retrospective study</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1091</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1091</guid>
<pubDate>Mon, 22 Apr 2013 08:16:32 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Diagnostic yield of video capsule endoscopy (VCE) may be higher if it is performed closer to the time of overt obscure GI bleeding (OOGIB).</p>
<p>OBJECTIVE: To evaluate the diagnostic yield of VCE and rate of therapeutic intervention for OOGIB for inpatients and outpatients with respect to timing of the intervention.</p>
<p>DESIGN: Retrospective cohort study.</p>
<p>SETTING: Tertiary academic center.</p>
<p>PATIENTS: Patients who had VCE for OOGIB between August 2008 and August 2010.</p>
<p>INTERVENTIONS: VCE for inpatients versus outpatients.</p>
<p>MAIN OUTCOME MEASURES: Diagnostic yield and rate of therapeutic intervention for inpatients versus outpatients.</p>
<p>RESULTS: One hundred forty-four inpatients (65 women) and 116 outpatients (49 women) were included. Diagnostic yield was 65.9% for inpatients versus 53.4% for outpatients (P = .054). Inpatients were divided into those who had VCE within 3 days (<3 >days; n = 90) of admission versus after 3 days (>3 days; n = 54). Active bleeding and/or an angioectasia was found in 44.4% of the 3-day group (P = .046) versus 25.8% of the outpatients. Therapeutic intervention was performed in 18.9% of the 3-day group (P = .046) versus 10.3% of outpatients. Diagnostic yield and therapeutic intervention rate between the >3-day group and outpatients were not significantly different. Length of stay (days) was less in the 3-day cohort (P < .0001).</p>
<p>LIMITATIONS: Long-term outcomes were not studied. This was a retrospective study.</p>
<p>CONCLUSIONS: Early deployment of VCE within 3 days of admission results in a higher diagnostic yield and therapeutic intervention rate and an associated reduction of length of stay. Mosby, Inc. All rights reserved.</p>

	]]>
</description>

<author>Anupam Singh et al.</author>


</item>






<item>
<title>An Evaluation of the Veterans Affairs Traumatic Brain Injury Screening Process Among Operation Enduring Freedom and/or Operation Iraqi Freedom Veterans</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1090</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1090</guid>
<pubDate>Mon, 22 Apr 2013 08:16:30 PDT</pubDate>
<description>
	<![CDATA[
	<p>OBJECTIVE: To describe the early results of the U.S. Department of Veterans Affairs (VA) screening program for traumatic brain injury (TBI) and to identify patient and facility characteristics associated with receiving a TBI screen and results of the screening.</p>
<p>DESIGN: National retrospective cohort study.</p>
<p>SETTING: VA Medical facilities.</p>
<p>PATIENTS: A total of 170,681 Operation Enduring Freedom and/or Operation Iraqi Freedom (OEF/OIF) Veterans who sought care at VA medical facilities from April 2007 to September 30, 2008.</p>
<p>METHODS: Data were abstracted from VA administrative and operational databases, including patient demographics, facility characteristics, and outcomes.</p>
<p>MAIN OUTCOME MEASUREMENTS: The main outcomes were receipt of and results of the TBI screen.</p>
<p>RESULTS: The majority of veterans eligible received the TBI screen (91.6%). Screening rates varied by patient and facility characteristics. In all, 25% of screened veterans had probable TBI exposure, in which the majority of the exposures were blasts (85.0%). The rate of a positive TBI screen was 20.5% for the screened cohort. Male gender, service in the army, multiple deployments, and mental health diagnoses in the previous year were associated with a positive screen.</p>
<p>CONCLUSIONS: TBI screening rates are high in VA; concomitant mental health diagnoses were highly prevalent in individuals with positive TBI screens. These data indicate that there will be a significant need for long-term health care services for veterans with TBI symptomatology. Published by Elsevier Inc. All rights reserved.</p>

	]]>
</description>

<author>Charlesnika T. Evans et al.</author>


</item>






<item>
<title>Comparison of Medication Practices in Patients With Heart Failure and Preserved Versus Those With Reduced Ejection Fraction (from the Cardiovascular Research Network [CVRN])</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1089</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1089</guid>
<pubDate>Mon, 22 Apr 2013 08:16:28 PDT</pubDate>
<description>
	<![CDATA[
	<p>Limited data exist describing the differences in the medical treatment of patients with heart failure with preserved ejection fraction (HF-PEF) from those with heart failure with reduced ejection fraction (HF-REF) in more generalizable population-based cohorts. We studied patients with incident HF diagnosed from 2005 to 2008 from 4 sites participating in the Cardiovascular Research Network. These patients, their medication profile, and left ventricular systolic function status were identified from the hospital discharge and ambulatory visit diagnoses, pharmacy dispensing information, and imaging reports found in the health plan electronic databases and through chart review. The study population consisted of 6,210 patients with newly diagnosed HF-PEF and 3,914 patients with newly diagnosed HF-REF. The mean age of our study population was 73 years, 48% were women, and 74% were white. The patients with HF-REF were less likely to have been treated with various cardiac and HF-related medications before their index HF event; however, they were significantly more likely to have been treated with new cardiac medications and HF therapies after the diagnosis of HF than were the patients with HF-PEF. After controlling for several potentially confounding factors, the patients with HF-PEF were significantly less likely to have been treated with multiple cardiac drug regimens (adjusted odds ratio 0.69, 95% confidence interval 0.59 to 0.81) and multiple HF-related therapies (adjusted odds ratio 0.40, 95% confidence interval 0.38 to 0.42) than were patients with HF-REF. In conclusion, the present results from a large, population-based sample suggest considerable variation in the previous and new use of different cardiac medication classes of drugs in patients with HF-PEF versus HF-REF.</p>

	]]>
</description>

<author>Robert J. Goldberg et al.</author>


</item>






<item>
<title>Patterns of prophylactic gastrostomy tube placement in head and neck cancer patients: A consideration of the significance of social support and practice variation</title>
<link>http://escholarship.umassmed.edu/qhs_pp/1088</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/qhs_pp/1088</guid>
<pubDate>Mon, 22 Apr 2013 08:16:26 PDT</pubDate>
<description>
	<![CDATA[
	<p>OBJECTIVES/HYPOTHESIS: The purpose of this study was to examine factors associated with prophylactic placement of feeding tubes in head and neck cancer patients receiving radiation therapy as a part of treatment using multilevel models that account for patient-, physician-, and institution-level sources of variation.</p>
<p>STUDY DESIGN: A retrospective analysis using binary logistic regression and hierarchical linear models was run to evaluate independent predictors of prophylactic feeding tube placement.</p>
<p>METHODS: Surveillance, Epidemiology, and End Results-Medicare data were used. Head and neck cancer patients diagnosed with locoregionally advanced stage disease from 2000 to 2005 were included in this study (N = 8,306).</p>
<p>RESULTS: Across all models, prophylactic gastrostomy tube placement was found to be more likely in patients who had cancer of the larynx or oropharynx compared with those with cancer of the nasopharynx or oral cavity; who had regional instead of local cancer; who did not receive surgery as a part of treatment, but did receive chemotherapy; and who were divorced, separated, or widowed. Additionally, although practice variation was observed to occur, its overall contribution in predicting prophylactic gastrostomy tube placement was minimal.</p>
<p>CONCLUSIONS: As health care enters an era of patient-centered care, further investigation of the potential role of social support (or lack of social support) in influencing treatment decisions of head and neck cancer patients and providers is warranted. LEVEL OF EVIDENCE: 2b Laryngoscope, 2013. Society, Inc.</p>

	]]>
</description>

<author>Julie L. Locher et al.</author>


</item>





</channel>
</rss>
